Interactive Investor
>>

Vicore Pharma Holding AB (OMX:VICO) Share Price

VICO

Vicore Pharma Holding AB

European company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XSTO

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Vicore Pharma Holding AB is a drug development company. The company's through is a subsidiary is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin system. Its drug candidate, C21, is the first small molecule compound in its class.Vicore Pharma Holding AB is a drug development company. The company's through is subsdiary is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin systemet.

OMX:VICO

SE0007577895

SEK

Loading...

Loading Comparison

Latest VICO News